Sort
46,585 grants matching “heart failure”
An Accurate Non-Contrast-Enhanced Cardiac MRI Method for Imaging Chronic Myocardial Infarctions: Technical Developments to Rapid Clinical Validation
$809,909Rohan Dharmakumar · Cedars-Sinai Medical Center · R01 · FY2018 · HL
Whole-Heart Myocardial Blood Flow Quantification Using MRI
$809,851Debiao Li · Cedars-Sinai Medical Center · R01 · FY2016 · HL
Oxidation-mediated structural degeneration of bioprosthetic heart valves
$809,825Robert J Levy · Children'S Hosp Of Philadelphia · R01 · FY2019 · HL
Engineered Stem Cells for Cardiac Repair
$809,808Michael Regnier · University Of Washington · R01 · FY2022 · HL
Chronic Kidney Disease in Children Study (C-Kid)
$809,580Susan L Furth · Johns Hopkins University · U01 · FY2007 · DK
Resuscitating the Brain and Heart Following Cardiac Arrest: Targeting Oxygen Toxicity
$809,442Willard William Sharp · University Of Chicago · R01 · FY2025 · HL
Hispanic Community Health Study
$809,175Neil Schneiderman · University Of Miami Coral Gables · N01 · FY2010 · HL
Microstructural Response of the Myocardium to Mechanical Load
$809,143David E Sosnovik · Massachusetts General Hospital · R01 · FY2023 · HL
Microstructural Response of the Myocardium to Mechanical Load
$809,143David E Sosnovik · Massachusetts General Hospital · R01 · FY2022 · HL
A Randomized Controlled Trial of Gamification and Social Incentives to Increase Adherence to Physical Activity Among Patients with Heart Failure with Preserved Ejection Fraction
$809,029Alexander Craig Fanaroff · University Of Pennsylvania · R01 · FY2024 · HL
Preclinical Development of a Novel eNAMPT-Neutralizing mAb for Pulmonary Hypertension
$809,000Joe G. N. Garcia · Aqualung Therapeutics Corp. · R42 · FY2023 · HL
Preclinical Development of a Novel eNAMPT-Neutralizing mAb for Pulmonary Hypertension
$808,999Joe G. N. Garcia · Aqualung Therapeutics Corp. · R42 · FY2024 · HL
Calcium Pump Activators for Heart Failure Therapy
$808,914David Dale Thomas · University Of Minnesota · R01 · FY2015 · HL
Development of a Novel Immunomodulatory Pyridone for the Treatment of Heart Failure with Preserved Ejection Fraction
$808,812Jennifer Baltz · I-Cordis, Llc · R44 · FY2022 · HL
Mediators of Systemic Inflammation and Heart Failure Risk in the Community
$808,739Susan Cheng · Cedars-Sinai Medical Center · R01 · FY2022 · HL
Informing optimal first-line antihypertensive therapy: A rigorous comparative effectiveness analysis of ARBs vs. ACEIs on long-term risk of dementia, cancer, heart disease, and quality of life
$808,711Jordana B. Cohen · University Of Pennsylvania · R01 · FY2022 · AG
Inhibition of Galectin-3 for Therapy of Remodeling After Myocardial Infarction
$808,592Constance M John · Mandalmed, Inc. · R44 · FY2017 · AG
Predictive and systems modeling of exosome cargo
$808,518Michael E Davis · Emory University · R01 · FY2019 · HL
CORAL: Data Coordinating Center
$808,482Donald Cutlip · Beth Israel Deaconess Medical Center · U01 · FY2007 · HL
Neuromaturational Delays in Iron Deficient Anemic Infants
$808,336Betsy Lozoff · University Of Michigan At Ann Arbor · R01 · FY2010 · HD
TASK AREA A - MESA CORE OPERATIONS, FIELD CENTER.
$808,268Karol Watson · University Of California Los Angeles · N01 · FY2024 · HL
Genetic Contribution to Graft and Patient Outcomes
$808,200Adriana V Zeevi · University Of Pittsburgh At Pittsburgh · P50 · FY2007 · HL
Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk
$808,114Takara Leah Stanley · Massachusetts General Hospital · R01 · FY2019 · DK
Impact of Interventions on Future Trends in Subnational Burden of Cardiovascular Diseases in the US
$808,029Gregory Andrew Roth · University Of Washington · R01 · FY2024 · HL
Structure and function of voltage-gated calcium channels
$808,022Daniel L Minor · University Of California, San Francisco · R01 · FY2022 · HL